Generic drugmakers and their investors have so far shrugged off a state lawsuit and federal investigation into possible price collusion. That may be the right bet, but there are a few things that investors should watch closely.
from WSJ.com: Markets http://ift.tt/2yXZLjc
via https://ifttt.com/ IFTTT
No comments:
Post a Comment